These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 18212687)

  • 1. Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.
    Van Tongeren RB; Hamming JF; Fibbe WE; Van Weel V; Frerichs SJ; Stiggelbout AM; Van Bockel JH; Lindeman JH
    J Cardiovasc Surg (Torino); 2008 Feb; 49(1):51-8. PubMed ID: 18212687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease.
    Franz RW; Parks A; Shah KJ; Hankins T; Hartman JF; Wright ML
    J Vasc Surg; 2009 Dec; 50(6):1378-90. PubMed ID: 19837539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial.
    Gabr H; Hedayet A; Imam U; Nasser M
    Exp Clin Transplant; 2011 Jun; 9(3):197-202. PubMed ID: 21649569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease.
    Franz RW; Shah KJ; Pin RH; Hankins T; Hartman JF; Wright ML
    J Vasc Surg; 2015 Sep; 62(3):673-80. PubMed ID: 26304481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.
    Abdul Wahid SF; Ismail NA; Wan Jamaludin WF; Muhamad NA; Abdul Hamid MKA; Harunarashid H; Lai NM
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010747. PubMed ID: 30155883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia.
    Klepanec A; Mistrik M; Altaner C; Valachovicova M; Olejarova I; Slysko R; Balazs T; Urlandova T; Hladikova D; Liska B; Tomka J; Vulev I; Madaric J
    Cell Transplant; 2012; 21(9):1909-18. PubMed ID: 22472173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia.
    Napoli C; Farzati B; Sica V; Iannuzzi E; Coppola G; Silvestroni A; Balestrieri ML; Florio A; Matarazzo A
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):709-18. PubMed ID: 19050436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
    Moazzami K; Moazzami B; Roohi A; Nedjat S; Dolmatova E
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD008347. PubMed ID: 25525690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Repeated Bone Marrow Mononuclear Cell Therapy in Patients with Critical Limb Ischemia in a Pilot Randomized Controlled Trial.
    Molavi B; Zafarghandi MR; Aminizadeh E; Hosseini SE; Mirzayi H; Arab L; Baharvand H; Aghdami N
    Arch Iran Med; 2016 Jun; 19(6):388-96. PubMed ID: 27293053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans.
    Huang PP; Yang XF; Li SZ; Wen JC; Zhang Y; Han ZC
    Thromb Haemost; 2007 Dec; 98(6):1335-42. PubMed ID: 18064333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
    Moazzami K; Majdzadeh R; Nedjat S
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008347. PubMed ID: 22161427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of purified CD34+ cells in the treatment of critical limb ischemia.
    Dong Z; Chen B; Fu W; Wang Y; Guo D; Wei Z; Xu X; Mendelsohn FO
    J Vasc Surg; 2013 Aug; 58(2):404-411.e3. PubMed ID: 23611711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited value of digital subtraction angiography in the evaluation of cell-based therapy in patients with limb ischemia.
    van Tongeren RB; Hamming JF; le Cessie S; van Erkel AR; van Bockel JH
    Int J Cardiovasc Imaging; 2010 Jan; 26(1):19-25. PubMed ID: 19757148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
    Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
    J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous Bone Marrow-Derived Stem Cells in Patients with Severe Peripheral Arterial Disease.
    Sharma S; Pandey NN; Sinha M; Kumar S; Jagia P; Gulati GS; Gond K; Mohanty S; Bhargava B
    J Vasc Interv Radiol; 2021 Feb; 32(2):157-163. PubMed ID: 33248918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.
    Amann B; Luedemann C; Ratei R; Schmidt-Lucke JA
    Cell Transplant; 2009; 18(3):371-80. PubMed ID: 19500466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia.
    Zafarghandi MR; Ravari H; Aghdami N; Namiri M; Moazzami K; Taghiabadi E; Fazel A; Pournasr B; Farrokhi A; Sharifian RA; Salimi J; Moini M; Baharvand H
    Cytotherapy; 2010 Oct; 12(6):783-91. PubMed ID: 20078390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.
    Malyar NM; Radtke S; Malyar K; Arjumand J; Horn PA; Kröger K; Freisinger E; Reinecke H; Giebel B; Brock FE
    Cytotherapy; 2014 Sep; 16(9):1270-9. PubMed ID: 24972744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autologous bone-marrow stem-cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia].
    Amann B; Lüdemann C; Ratei R; Schmidt-Lucke JA
    Zentralbl Chir; 2009 Aug; 134(4):298-304. PubMed ID: 19688676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.